LSE:AZNPharmaceuticals
AstraZeneca Reshapes US And European Operations Under Tariff And Pricing Pressures
AstraZeneca (LSE:AZN) is expanding US manufacturing to secure relief from new US pharmaceutical import tariffs.
The company is also cutting some US drug prices as part of its response to recent US trade and pricing measures.
In parallel, AstraZeneca is delaying certain product launches in Europe to adjust to changing pricing and regulatory conditions.
AstraZeneca, a major global biopharma player, relies heavily on prescription medicines across oncology, cardiovascular and respiratory...